Galmed Pharmaceuticals Share Price (NASDAQ: GLMD)
$1.27
Last updated on
Check the interactive Galmed Pharmaceuticals Stock chart to analyse performance
Galmed Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.26Today's High:$1.30
0.79%
Downside
Day's Volatility :3.08%
Upside
2.31%
- 52 Weeks Low:$1.1552 Weeks High:$23.80
9.45%
Downside
52 Weeks Volatility :95.17%
Upside
94.66%
Galmed Pharmaceuticals Stock Returns
Galmed Pharmaceuticals Ltd Key Stats
Check Galmed Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Galmed Pharmaceuticals Stock including INR - Dollar returns
The Galmed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Galmed Pharmaceuticals investment value today
Current value as on today
₹42,858
Returns
Returns from Galmed Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Galmed Pharmaceuticals Stock
Global Institutional Holdings in Galmed Pharmaceuticals Ltd
Name
Holdings %
Schonfeld Strategic Advisors LLC
0.42%
Virtu Financial LLC
0.20%
TWO SIGMA SECURITIES, LLC
0.20%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.19%
Morgan Stanley - Brokerage Accounts
0.14%
UBS Group AG
0.02%
Analyst Recommendation on Galmed Pharmaceuticals Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Galmed Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Galmed Pharmaceuticals Share Price Target
What analysts predicted
Upside of 844.88%
Target:
$12.00
Current:
$1.27
Galmed Pharmaceuticals share price target is $12.00, a slight Upside of 844.88% compared to current price of $1.27 as per analysts' prediction.
Galmed Pharmaceuticals Stock Insights
Price Movement
In the last 7 days, GLMD stock has moved down by -12.8%GLMD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 131.4%GLMD vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 211.0%
Galmed Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Galmed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Galmed Pharmaceuticals Ltd Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -20.25% | -32.99% | -58.47% | -98.38% | -99.85% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.02 | NA | 0.0 | -3.26 | -0.5 | -0.23 | NA | 7.47 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $7.6M | -99.85% | 0.02 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Galmed Pharmaceuticals Ltd
Key Management of Galmed Pharmaceuticals Ltd
Important FAQs about investing in GLMD Stock from India :
What is Galmed Pharmaceuticals share price today?
Galmed Pharmaceuticals share price today is $1.27 as on at the close of the market. Galmed Pharmaceuticals share today touched a day high of $1.30 and a low of $1.26.
What is the 52 week high and 52 week low for Galmed Pharmaceuticals share?
Galmed Pharmaceuticals share touched a 52 week high of $23.80 and a 52 week low of $1.15. Galmed Pharmaceuticals stock price today i.e. is closed at $1.27, lower by 94.66% versus the 52 week high.
How to invest in Galmed Pharmaceuticals Stock (GLMD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Galmed Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galmed Pharmaceuticals Shares that will get you 1.1811 shares as per Galmed Pharmaceuticals share price of $1.27 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Galmed Pharmaceuticals Stock (GLMD) from India?
Indian investors can start investing in Galmed Pharmaceuticals (GLMD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Galmed Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Galmed Pharmaceuticals share’s latest price of $1.27 as on August 30, 2025 at 1:29 am IST, you will get 7.8740 shares of Galmed Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Galmed Pharmaceuticals has given to Indian investors in the last 5 years?
Galmed Pharmaceuticals stock has given -99.85% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%